LOEWS CORP (L)

US5404241086 - Common Stock

85.17  +0.68 (+0.8%)

Premarket: 83.51 -1.66 (-1.95%)

Fundamental Rating

4

Taking everything into account, L scores 4 out of 10 in our fundamental rating. L was compared to 140 industry peers in the Insurance industry. L has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, L is valued expensive at the moment.



5

1. Profitability

1.1 Basic Checks

L had positive earnings in the past year.
In the past year L had a positive cash flow from operations.
L had positive earnings in 4 of the past 5 years.
Each year in the past 5 years L had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.00%, L is in line with its industry, outperforming 52.52% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.64%, L is in line with its industry, outperforming 46.04% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.52%, L is in line with its industry, outperforming 55.40% of the companies in the same industry.
L had an Average Return On Invested Capital over the past 3 years of 2.15%. This is below the industry average of 4.27%.
The 3 year average ROIC (2.15%) for L is below the current ROIC(2.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2%
ROE 9.64%
ROIC 2.52%
ROA(3y)1.6%
ROA(5y)0.96%
ROE(3y)7.87%
ROE(5y)4.65%
ROIC(3y)2.15%
ROIC(5y)N/A

1.3 Margins

L has a better Profit Margin (9.71%) than 60.43% of its industry peers.
In the last couple of years the Profit Margin of L has grown nicely.
Looking at the Operating Margin, with a value of 15.39%, L is in the better half of the industry, outperforming 66.91% of the companies in the same industry.
L's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.39%
PM (TTM) 9.71%
GM N/A
OM growth 3YN/A
OM growth 5Y7.28%
PM growth 3YN/A
PM growth 5Y14.84%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), L is destroying value.
L has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, L has less shares outstanding
The debt/assets ratio for L has been reduced compared to a year ago.

2.2 Solvency

L has a debt to FCF ratio of 5.07. This is a neutral value as L would need 5.07 years to pay back of all of its debts.
The Debt to FCF ratio of L (5.07) is worse than 63.31% of its industry peers.
L has a Debt/Equity ratio of 0.51. This is a neutral value indicating L is somewhat dependend on debt financing.
L has a Debt to Equity ratio of 0.51. This is in the lower half of the industry: L underperforms 63.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 5.07
Altman-Z N/A
ROIC/WACC0.35
WACC7.19%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.77% over the past year.
The Earnings Per Share has been growing by 24.34% on average over the past years. This is a very strong growth
The Revenue has grown by 12.64% in the past year. This is quite good.
L shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)26.77%
EPS 3YN/A
EPS 5Y24.34%
EPS Q2Q%62.5%
Revenue 1Y (TTM)12.64%
Revenue growth 3Y7.8%
Revenue growth 5Y2.45%
Sales Q2Q%13.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.31 indicates a reasonable valuation of L.
L's Price/Earnings ratio is a bit cheaper when compared to the industry. L is cheaper than 63.31% of the companies in the same industry.
L's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.96.
Industry RankSector Rank
PE 11.31
Fwd PE N/A

4.2 Price Multiples

L's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. L is cheaper than 66.91% of the companies in the same industry.
L's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 9.87
EV/EBITDA 8.63

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.30%, L is not a good candidate for dividend investing.
L's Dividend Yield is slightly below the industry average, which is at 4.25.
Compared to an average S&P500 Dividend Yield of 2.23, L's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of L has a limited annual growth rate of 0.03%.
L has paid a dividend for at least 10 years, which is a reliable track record.
L has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.03%
Div Incr Years0
Div Non Decr Years9

5.3 Sustainability

3.35% of the earnings are spent on dividend by L. This is a low number and sustainable payout ratio.
L's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP3.35%
EPS Next 2YN/A
EPS Next 3YN/A

LOEWS CORP

NYSE:L (11/21/2024, 8:04:00 PM)

Premarket: 83.51 -1.66 (-1.95%)

85.17

+0.68 (+0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.55B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.31
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 2%
ROE 9.64%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.39%
PM (TTM) 9.71%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)26.77%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.64%
Revenue growth 3Y7.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y